1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anti-Infective Drug News 13 APRIL 2015

Anti-Infective Drug News 13 APRIL 2015

  • April 2015
  • -
  • Espicom Business Intelligence
  • -
  • 28 pages

Industry Trend Analysis - Viable Generic Sofosbuvir Market Will Increase Pricing Pressures For Gilead
Industry Brief - FDA Approves Sanofi's Quadracel DTaP-IPV Vaccine For Children Aged Four Through Six
Industry Brief - GSK To Provide Meningitis B Vaccine In UK
Industry Brief - EC Approves Kengrexal/Orbactiv/Raplixa
Industry Brief - AmpliPhi Granted EU Patent For Bacteriophage Therapy In Biofilm-Related Bacterial Infections
Industry Brief - Vantobra Granted EC Approval For Cystic Fibrosis
Industry Brief - Synthetic Biologics Initiates Phase IIa Trial Of SYN-004 In Microbiome/CDI
Industry Brief - Vernalis/Taisho Enter Drug Discovery Collaboration
Industry Trend Analysis - Emergent's Biodefence Products Will Fuel Development Of Its Commercial Pipeline
Industry Brief - Takeda Seeks Japanese Approval For Single Pack Containing Takecab For H. Pylori Eradication
Industry Trend Analysis - Diagnostics Are Key To Combatting Antibiotic Resistance
Industry Trend Analysis - Nabriva's Novel Antibiotic Will Draw In Further Attention After Stirring Investors
Industry Brief - Vical In-Licenses Antifungal Drug ASP2397 From Astellas
Industry Brief - Moberg Granted EU Patent Covering MOB-015 For Onychomycosis
Industry Brief - M72 TB Vaccine Trial Enters Final Phase
Industry Trend Analysis - Opportunities For Vaccine Manufacturers Still Exist Despite Waning Ebola Crisis
Industry Brief - FDA Grants Fast Track Designation For MedImmune's RSV Vaccine In LRTI Prevention
Industry Brief - Merck's Grazoprevir/Elbasvir Regimen Gains FDA Breakthrough Therapy Designations
Industry Trend Analysis - More Granular Studies Will Command Direction Of HCV Market
Industry Brief - Gardasil 9 HPV Vaccine Available In Canada
Industry Brief - CHMP Adopts Positive Opinion On Gardasil 9 HPV Vaccine
Industry Brief - FDA Warns Use Of Amiodarone With HCV Treatments Containing Sofosbuvir In Combination
Industry Brief - Copegus/Sovaldi Combination Therapy Approved In Japan For GT2 HCV
Industry Brief - BioCryst Awarded BARDA Contract To Support BCX4430 Development
Industry Brief - German Court Dismisses Microbix' Virusmax Lawsuit Against Novartis
Industry Brief - Sovaldi Approved In Japan For HCV GT2
Industry Brief - Ebola Test Vaccines Appear Safe In Phase II Liberian trial
Industry Brief - Harvoni Accepted For Public Reimbursement In Canada For HCV GT1
Industry Brief - B66-Based Prototype pandemic Flu Vaccine Gains Japanese Approval
Industry Brief - Ebola Vaccine Shows Promise In First Phase I trial
Industry Trend Analysis - Gilead To Maintain Dominance In HIV Market
Industry Brief - FDA Accepts Remune HIV/AIDS Vaccine BLA For Review
Industry Brief - GSK To Establish Global Vaccines R&D Centre In US
Industry Trend Analysis - Recent Agreements Highlight Sanofi Pasteur's Increasing Focus On Thermostable Vaccines
Industry Brief - Pfizer To Cease Vaccines Sales Business In China
Industry Brief - Novavax Raises Funds In Public Share Offering
Industry Brief - Insmed Raises Funds In Public Share Offering
Industry Brief - Rigontec Raises Funds To Advance RNA-Based Immunotherapeutics For Cancer/Viral Diseases
Industry Brief - Levon to Acquire SciVac
Industry Brief - Coronado Forms New Subsidiary DiaVax To Develop CMV Immunotherapies

Table Of Contents

Anti-Infective Drug News 13 APRIL 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. In this report, ...

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19

  • $ 4995
  • Industry report
  • November 2016
  • by GBI Research

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19 Summary Cancer vaccines are being ...

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

  • $ 4995
  • Industry report
  • January 2017
  • by GBI Research

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance Summary The antibacterial drug market covers ...


Download Unlimited Documents from Trusted Public Sources

HIV AIDS Statistics and HIV Antiviral Market in China

  • February 2017
    11 pages
  • HIV AIDS  

    Infectious Dise...  

    HIV Antiviral  

  • China  

    United States  

View report >

Chemotherapy Market in the US

  • February 2017
    9 pages
  • Chemotherapy  

  • United States  

View report >

Therapy and Hormone Market in China

  • February 2017
    9 pages
  • Therapy  

    Hormone  

    Smoking Statist...  

  • China  

View report >

Related Market Segments :

Infectious Disease

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.